HONG KONG, CHINA - Media
OutReach - 12 November 2019 - Jacobson Pharma Corporation Limited ("Jacobson
Pharma" or the "Group"; Stock Code:
2633), a leading company engaging in research, development, production,
marketing and sale of generic drugs and proprietary medicines, announced the launch of Smartfish's
health nutrition range of products in Greater China (including Mainland China,
Hong Kong, Macau and Taiwan) and Asia under an exclusive distribution agreement
with Smartfish AS, a branded health nutrition company
incorporated in Norway.
Smartfish provides products for the consumer health nutrition range and is the official supplier of sports nutrition drinks to sports clubs and national teams, including English Premier League Tottenham Hotspurs Football Club
According
to the agreement, the Group has an in-licensed right for 10 years to distribute
and market Smartfish's consumer health products
in Greater China and the Asia Pacific Region, covering four product ranges,
namely "Smartfish Recharge" for sports nutrition, "Smartfish Resolve" for
improving metabolic health and diabetes care, "Smartfish Reflect" for promoting
adults' brain health and cognitive function, and "Smartfish Cream" for
benefiting children's brain development
Built
upon a patented emulsion technology and clinically substantiated, Smartfish's Omega-3-enhanced nutritional drinks and
emulsion products complement the fast-growing medical and consumer nutrition markets
with products of evidence-based health benefits.
Differentiated from standard fish oil
supplements, Smartfish's emulsion carries high levels of Omega 3 fatty acids,
in synergy with other nutrients, that can produce the potentiating
anti-inflammatory effects to deliver various health benefits . It can also
ensure a tasty delivery of nutrients by protecting Omega-3 fatty acids, which
are rich in fish oil, from oxidizing and forming the rancid taste. The products
are clinically tested, and all health benefit claims for Smartfish products are
supported by rigorous science.
Smartfish's
products range provides health nutrition for the elderly and the young, medical
nutrition for chronic disease patients, and sports nutrition for athletes. Smartfish
has established itself as a trusted nutritional source for professional
athletes worldwide being the official supplier of sports nutrition drinks to
sports clubs and national teams, which include English Premier League Tottenham
Hotspurs Football Club and Norwegian Nordic Combined National Team of Skiing.
Jacobson
Pharma's strategic collaboration with Smartfish also included a shareholding
investment of 9.04% of Smartfish's issued capital made in July 2019, which is
expected to forge a stronger partnership and platform for both companies on exploring
potential business cooperation in the high growing consumer health nutrition
market in the future.
Mr. Derek Sum,
Chairman and Chief Executive Officer of
Jacobson Pharma, comments, "We welcome
Smartfish's nutrition products with well-documented potency to our consumer
health product portfolio. The health
nutrition market has witnessed strong growth driven by the greater inclination
towards self-care and health problems prevention, alongside a growing aged
population and increase in disposable income. Through this collaboration,
Jacobson Pharma has primed itself to collaborate with Smartfish in exploiting
the latent demand for clinically substantiated health nutrition products to
meet different lifestyle and healthcare needs among consumers in Greater China
and the Asia Pacific Region."
About Jacobson Pharma Corporation Limited (雅各臣科研製藥有限公司；Stock Code: 2633)
Jacobson Pharma is a leading generic drug company in Hong Kong. The Group's
proprietary brand portfolio, notably being Po Chai Pills (「保濟丸」), Ho Chai Kung Tji Thung San (「何濟公止痛退熱散」), Contractubex Scar Gel (「秀碧除疤膏」) , Flying Eagle Wood Lok Medicated Oil (「飛鷹活絡油」), Tong Tai Chung Woodlok Oil (「唐太宗活絡油」), Doan's Ointment (「兜安氏藥膏」), Saplingtan (「十靈丹」), Shiling Oil (「十靈油」) and Col-gan Tablet (「傷風克」) have been widely recognised by the market. The Group aims to
enrich its portfolio through addition of high
value-added products covering sterile injections, oncology products as well as
orphan drugs and biosimilars. With its corporate headquarters based in Hong Kong, the Group has also
established its operating subsidiaries in China, Macau,
Taiwan, Singapore and Cambodia forming a regional commercial platform to tap the market
potential in the Asia Pacific and Greater China region. Jacobson Pharma
has been a constituent stock of MSCI Hong Kong Micro Cap Index since 1 June 2017.
For more details about Jacobson Pharma, please visit the Group's website:
http://www.jacobsonpharma.com
About Smartfish AS
Smartfish is a company
incorporated in Norway which focuses on research & development, production
and marketing of advanced, science-based and clinically documented nutritional
products. Smartfish provides unique nutritional solutions for both medical use
and consumer health. Its nutrition products are based on a proprietary emulsion
technology that enables the effective delivery of high levels of Omega 3 fatty
acids, whey protein and other nutrients.
Smartfish has a number of ongoing clinical development projects and
studies in the pipeline in close collaboration with renowned researchers and
institutions around the world. The company was founded in 2001 and is now
headquartered in Oslo, Norway with an operating subsidiary in Lund, Sweden.
Smartfish's main shareholders include Investinor (a Norwegian-based fund) and Industrifonden
(a Nordic fund). Learn more on www.smartfishnutrition.com.
http://www.media-outreach.com/release.php/View/20131#Contact